In this issue:
68Ga-RM2 PET-MRI for evaluation of prostate cancer
ADT intensification in biochemically relapsed CSPC
Pelvic irradiation for node-positive prostate cancer after prostatectomy
Association of BMI with tumour aggression
Focal therapy with high-intensity focused ultrasound
ADT and prostate cancer outcomes according to competing event risk
Neoadjuvant chemohormonal therapy vs hormonal therapy
Intermittent vs continuous ADT in CSPC
Risk factors for prostate cancer
Phase I study of acapatamab for mCRPC
Please login below to download this issue (PDF)